Welcome to HIVE

Our mission is to improve medication adherence for Outpatient Parenteral Antimicrobial Therapy (OPAT) patients. Doctors and pharmacists don't know which patients struggle to follow prescriptions, and as a result, unnecessary readmissions cost the healthcare system millions of dollars every year. With the HIVE device, HIVE will make OPAT more transparent for patients and their doctors. Bringing our product to the market will improve the quality of life of hundreds of thousands of OPAT patients across the nation, and that fuels us every day.

The Device ​

HIVE is developing a novel medical device that tracks medication adherence in OPAT patients at the PICC port location. The device will provide doctors and pharmacists with an objective record of compliance and improve patient health outcomes. 

The App

Patients will experience an all-in-one mobile application to provide them with reminders to take their medication, a clear record of past medication doses, educational videos, FAQs, rides to the hospital via Uber, a rewards system, refill authorization, and sync with doctors appointment times. ​ 

Strategic Partners

HIVE is partnered with Sling Health, a student-run biotechnology incubator that provides resources, training, and mentorship to teams of students tackling clinical problems by developing innovative solutions. We are also a member of the BioGenerator Fundamentals program, which has mentored many successful biotech startups. Finally, we are partnered with BJC Home Health Services and Washington University School of Medicine for clinical trials. These strategic partners work closely with us to ensure that our device impacts thousands of OPAT patients.

I am excited about this project. I think it has great potential in the real world. 
—Dr. Yasir Hamad, Assistant Professor, OPAT Medical Director, Washington University School of Medicine